Bruce L. A. Carter
"Dr. Bruce L A Carter was the Chairman of the Board and Chief Executive OU cer of ZymoGenetics Inc., USA. He has also served as the Corporate Executive Vice President and Chief Scientifi c OU cer for Novo Nordisk A/S. Dr. Carter held various positions of increasing responsibility at G.D. Searle & Co., Limited. He was a lecturer at Trinity College, University of Dublin, from 1975 to 1982. Dr. Carter holds directorship in Enanta Pharmaceutical Inc., Mirati Therapeutics Inc., Accelerator Corporation and TB Alliance, all in the US and our wholly-owned subsidiary, Aurigene Discovery Technologies Limited, in India. Dr. Carter received a B.Sc. with Honors in Botany from the University of Nottingham, England and a Ph.D. in Microbiology from Queen Elizabeth College, London University, UK." [1]
- Director, Dr Reddys
